Pharmaceutical Online Videos
-
Aldevron Capacity Update February 2024: Cell & Gene
2/28/2024
Examine Aldevron's custom manufacturing services and ready-for-use products to support your pipeline and review our new capacity for cGMP RNP manufacturing to streamline CRISPR gene editing programs.
-
Nanoform Capacity Update February 2024: Small Molecule
2/28/2024
Discover Nanoform’s manufacturing capabilities, its CESS technology for nanoparticle generation, and the types of particles that can be generated without the need for solvents or excipients.
-
Novartis Contract Manufacturing Capacity Update February 2024: Cell & Gene
2/28/2024
Gain an overview of the CGT manufacturing services provided by Novartis Contract Manufacturing and how the in-house capabilities within our network can support clients' needs in end-to-end production.
-
EirGenix Inc. Capacity Update February 2024: Large Molecule
2/28/2024
EirGenix has immediate availability of capacity up to 12 x 2,000 L SUBs for mammalian cells and up to 150 L scale for microbial and that will increase to 350L and 1,000L by end of this year.
-
Resilience US, Inc. Capacity Update February 2024: Large Molecule
2/28/2024
With a strong network of sites, Resilience provides innovative solutions and services for established and emerging therapies. Learn how we can support your development and manufacturing programs.
-
Singota Solutions Capacity Update February 2024: Large Molecule
2/28/2024
In this presentation from the February 2024 OPCU event, discover Singota’s capabilities in providing formulation development, analytical development, aseptic manufacturing, and supply chain services.
-
AGC Biologics Capacity Update February 2024: Cell & Gene
2/28/2024
In this presentation from the February 2024 OPCU event, learn more about the AGC Biologics’ global Cell and Gene network, track record, capabilities, and how it can provide support for any project.
-
ElevateBio Capacity Update February 2024: Cell & Gene
2/28/2024
Explore our facility as we share how our ecosystem brings together R&D, cGMP manufacturing, and groundbreaking technologies to help enhance speed, delivery, and probability of success to support CGTs.
-
Cambrex Capacity Update February 2024: Small Molecule
2/28/2024
Cambrex offers strong expertise in custom development and cGMP API manufacturing for small molecules, including HPAPI, through its Charles City, Iowa facility.
-
KBI Biopharma Capacity Update February 2024: Large Molecule
2/28/2024
Learn how KBI Biopharma is equipped to support drug development and biologics manufacturing and accelerate your timeline.